Roflumilast 250 mcg Oral Tablet
RxNorm 2001319
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2001319 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: roflumilast 250 mcg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Roflumilast 0.25 mg Oral Tablet
(Atom ID: 12350411)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely roflumilast 250 microgram/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12872190)
PSNPrescribable
Prescribable Name (PSN):
Roflumilast 250 mcg Oral Tablet
(Atom ID: 9736661)
SYPrescribable
Synonym (SY):
Roflumilast 250 mcg Oral Tablet
(Atom ID: 9736660)
PTPrescribable
Designated preferred name (PT):
Roflumilast 250 microgram oral tablet
(Atom ID: 12872243)
Patient Education
Roflumilast
Roflumilast is used in people with severe chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) to reduce the number of episodes or worsening of COPD symptoms. Roflumilast is in a class of medications called phosphodiesterase inhibitors. It works by decreasing swelling in the lungs.
[Learn More]
* Please review the disclaimer below.